Related Experiment Videos
Pneumoperitoneum after percutaneous endoscopic gastrostomy in patients in the intensive care unit
Joshua B Alley1, Michael G Corneille, Ronald M Stewart
1Department of Surgery, University of Texas Health Science Center at San Antonio, University Hospital, San Antonio, Texas 78229-3900, USA.
Insights
Pneumoperitoneum after percutaneous endoscopic gastrostomy (PEG) occurred in 6.7% of intensive care unit (ICU) patients. This finding, lower than historical rates, was not linked to PEG complications.
Area of Science:
- Medical procedures
- Gastroenterology
- Radiology
Background:
- Percutaneous endoscopic gastrostomy (PEG) is frequently associated with pneumoperitoneum.
- Existing literature reports up to a 55% incidence of pneumoperitoneum post-PEG.
Purpose of the Study:
- To determine the incidence and clinical significance of postprocedural pneumoperitoneum in intensive care unit (ICU) patients undergoing PEG.
- To compare current pneumoperitoneum rates with historical data.
Main Methods:
- Retrospective review of 120 consecutive PEG insertions in ICU patients.
- Analysis of chest radiographs within 48 hours post-procedure for pneumoperitoneum.
- Documentation of time to resolution for detected pneumoperitoneum.
- Examination of PEG-related complications.
Main Results:
- Post-PEG pneumoperitoneum was detected in 6.7% of ICU patients.
- The mean time to resolution of pneumoperitoneum was 2.7 days.
- The overall PEG complication rate was 10.8%, including dislodgement, transcolonic placement, and bleeding.
- No complications were associated with the presence of postprocedural pneumoperitoneum.
Conclusions:
- The incidence of post-PEG pneumoperitoneum in the ICU setting is 6.7%, which is lower than previously reported.
- Postprocedural pneumoperitoneum following PEG in ICU patients does not appear to be associated with increased complications.
Abstract:
Percutaneous endoscopic gastrostomy (PEG) has been associated with up to a 55 per cent incidence of pneumoperitoneum in the literature. A review was conducted of 120 consecutive PEG tube insertions in patients in the intensive care unit (ICU) to determine the incidence and significance of postprocedural pneumoperitoneum in this population. One hundred twenty consecutive PEG insertions in patients in the ICU were retrospectively reviewed. Chest radiographs were reviewed for 48 hours postprocedure, noting if any pneumoperitoneum was apparent on radiologic examination. If present, the time to resolution was noted. Documented PEG complications were also examined. Post-PEG pneumoperitoneum was detected in 6.7 per cent of patients in the ICU. Mean time to resolution was 2.7 days. The complication rate was 10.8 per cent, including dislodgement requiring laparotomy, transcolonic placement, and upper gastrointestinal bleeding. There were no complications resulting from PEG placement in patients with postprocedural pneumoperitoneum. Two transcolonic PEGs were undetected by postprocedure chest radiographs. The incidence of post-PEG pneumoperitoneum in our ICU population was 6.7 per cent. We believe that this incidence, although lower than historical rates, accurately reflects the current rate of detectable pneumoperitoneum in patients in the ICU. PEG-related complications were not associated with postprocedure pneumoperitoneum.
Related Concept Videos
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Endoscopic Procedures V: ERCP
Patient...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations: